10 Best Blue Chip Stocks to Buy for 2025

8. Eli Lilly and Company (NYSE:LLY)

Market Cap as of January 8: $707.96 Billion

Past Year Gain (2024): 26%

Number of Hedge Fund Holders: 106

Eli Lilly and Company (NYSE:LLY) is a company that discovers, develops, and markets human pharmaceuticals worldwide. It is one of the best blue chip stocks for 2025 amid growing demand for weight loss and diabetes treatment options. The company boasts of a robust pipeline of glucagon-like peptide-1 (GLP-1) receptor agonist drugs.

Eli Lilly and Company’s (NYSE:LLY) Mounjaro and Zepbound drugs are proving effective in helping patients lose weight, attracting billions of dollars in revenues. Mounjaro revenue more than doubled to $3.11 billion in Q3 as Zepbound added an additional $1.26 billion. Mounjaro stands out in helping patients with type 2 diabetes improve blood sugar, while Zepbound is effective in weight loss in obese adults.

Eli Lily’s long-term outlook remains solid, with management having projected a 50% year-over-year revenue increase for Q4. Strong demand for drugs is the catalyst behind the company’s increasing production capacity as it also looks to diversify its revenue streams with expansion into new international markets. Eli Lilly and Company (NYSE:LLY) is also in the process of investing $20 billion to build, upgrade and acquire manufacturing facilities as it looks to fulfill the ever-increasing drug orders.